Journal profile · GERIATRICS & GERONTOLOGY-NEUROSCIENCES
Frontiers in Aging Neuroscience
ISSN 1663-4365 · Frontiers Media S.A. · SWITZERLAND
Frontiers in Aging Neuroscience: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.16; fully open access; APC charged, amount not published; median 68 days to acceptance (140 articles, last 24 months); 721 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Frontiers in Aging Neuroscience is published by Frontiers Media S.A. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Functional Brain Connectivity Studies, together about 37.2% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Aging Neuroscience is a multidisciplinary journal that aims to foster the understanding of mechanistic processes associated with Central Nervous System (CNS) aging and age-related neuronal diseases. Led by Specialty Chief Editor Prof Thomas Wisniewski (New York University School of Medicine, USA), the journal places special emphasis on integrating findings from various sub-disciplines in neuroscience to provide translational insight into the aging process and neurological diseases associated with senescence. Indexed in PubMed Central (PMC), Scopus and SCIE, the journal also focuses on developing treatment strategies aimed at the conservation of neuronal function, which is critical for advancing our ability to understand, manage, and treat conditions associated with aging. Areas of interest include: alzheimer's disease and related dementias cellular and molecular mechanisms of brain-aging neurocognitive aging and behavior neuroinflammation and neuropathy parkinson’s disease and aging-related movement disorders. The journal addresses all aspects of CNS aging and neurological diseases and pathological events connected to this process, and welcomes submissions elucidating genetic, biophysical, genomic, proteomic, cellular, molecular, biochemical, endocrinal, immunological, physiological, pharmacological, and psychological/behavioral aspects of aging. Neuroimaging studies and clinical studies targeted to mechanistic aspects of neuronal aging/disease are also welcome. In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being. Manuscripts that are purely clinical or theoretical, lacking mechanistic insights into age-related processes, as well as those that solely focus on clinical trials, medical treatments, or disease-specific epidemiology without a fundamental basis in the neuroscience of aging, are not suitable for publication in this journal. Additionally, studies that are purely statistical or theoretical, without a fundamental basis in real-world aging neuroscience issues, do not align with the scope of this journal. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Aging Neurosc
From the journal's Aims & Scope
Research area (LetPub): GERIATRICS & GERONTOLOGY-NEUROSCIENCES
Editorial board by country: none in mainland China; most named United States 9, Italy 2, Colombia 2, Taiwan, China 1, Spain 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine15.1%
- Alzheimer's disease research and treatmentsMedicine12.9%
- Functional Brain Connectivity StudiesNeuroscience9.3%
- Parkinson's Disease Mechanisms and TreatmentsMedicine8.7%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.6%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4.2%
- Advanced Neuroimaging Techniques and ApplicationsMedicine4%
- Neurological disorders and treatmentsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 3 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbasePsycINFOPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.16LetPub ·
- Impact factor (publisher)
- 5.2Publisher website ·
- CiteScore 2026-06
- 10LetPub ·
- CiteScore (publisher)
- 10Publisher website ·
- SJR 2026-06
- 1.51LetPub ·
- SNIP 2026-06
- 1.28LetPub ·
- h-index
- 55LetPub ·
- h-index
- 175OpenAlex ·
- i10-index
- 5,171OpenAlex ·
- 2-year mean citedness
- 4.84OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 681LetPub ·
Articles by year OpenAlex count · 8,503 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 728 | 728 | 283 |
| 2025 | 721 | 721 | 3,514 |
| 2024 | 623 | 623 | 6,228 |
| 2023 | 874 | 874 | 13,973 |
| 2022 | 1,588 | 1,588 | 34,980 |
| 2021 | 964 | 964 | 29,410 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
68 daysMedian, submission to acceptance · P25–P75 47 days – 111 days
- Acceptance to online
- median 20 days (140 articles)
- Submission to online
- median 93 days
- Sample
- 140 articles with submission and acceptance dates (1,540 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 3,150 | Yes | CC BY | |
| OpenAlex | CHF 3,150 | — | — | |
| LetPub | USD 3,295 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- SWITZERLAND
- Language
- English
- ISSN
- 1663-4365
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Aging Neuroscience
What CAS zone is Frontiers in Aging Neuroscience in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Aging Neuroscience is in Zone 3 of Medicine, and in Zone 3 of the minor category Geriatrics & Gerontology / Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Aging Neuroscience?
The latest impact factor listed by LetPub is 5.16; CiteScore 10, h-index 175.
How long does peer review take at Frontiers in Aging Neuroscience?
Based on the dates recorded on 140 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 47–111 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Frontiers in Aging Neuroscience based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), Italy (2) and Colombia (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Aging Neuroscience?
According to LetPub and DOAJ records, Frontiers in Aging Neuroscience is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, Embase and PsycINFO; that list has not been checked against each database.
Is Frontiers in Aging Neuroscience open access, and what is the APC?
Frontiers in Aging Neuroscience is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .